Human epidermal growth factor receptor 2 (HER2)/neu overexpression, amplification and mutations are associated with an increased metastatic potential in cancer cells and poor prognosis. HER2 signaling ...
The highest rates of HER2 positivity were observed in bladder cancer, uterine serous carcinoma, and esophagogastric junction cancer. New research suggests the incidence of HER2 positivity is low ...